[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"The "Consumer Health" spin-off trend exemplified by $JNJ's separation of Kenvue ($KVUE) is creating pure-play giants that compete directly with $PG and $UL in the over-the-counter medicine and wellness space"
X Link @EhabJobran1 2025-10-15T10:09Z X followers, X engagements
"The "Bio-Ink" market for 3D bioprinting tissues is a niche but growing segment for companies like $SSYS (Stratasys) supplying research tools that could one day disrupt the organ transplant market a concern far beyond the current scope of $JNJ's medical devices"
X Link @horan_weronika 2025-10-15T10:08Z XX followers, XX engagements
"@Radencnc @GenExDividend Will be interesting to see how it goes. With $KVUE they never issued shares to $JNJ shareholders. $JNJ so far kept the shares in their corporate holdings so $JNJ shareholders own $KVUE indirectly via $JNJ's corporate holdings. (Disc: I'm long $JNJ)"
X Link @ianlopuch 2025-10-14T18:21Z 21.3K followers, XX engagements
"🦉 Genmab $GMAB: DARZALEX sales reached $3.67B in Q3 2025 driven by strong global demand. Genmab earns royalties from $JNJs cancer drug sales. $GMAB $JNJ #stocks #announcement"
X Link @AponiaAnalytics 2025-10-14T14:38Z 5195 followers, XXX engagements